Recombinetics Announces Collaboration with Mayo Clinic to Grow Human Cardiomyocytes in Swine for Exo-transplantation
Recombinetics today announced a multi-project, collaborative research and development agreement with Mayo Clinic to advance capabilities to bioengineer human stem cells within swine models. The collaboration is focused on utilizing human stem cells to produce human tissue products in a surrogate pig for exo-transplantation back into humans. These regenerative stem [...]
Recombinetics Announces New Board of Directors with Representatives from a Series A Strategic Investor: Gundersen Health System
Recombinetics today announced its new board of directors following this week’s completion of a $34 million Series A financing round. Gundersen Health System, a physician-led, not-for-profit healthcare system with locations in Wisconsin, Minnesota and Iowa, led the round as a strategic investor and now has three representatives on Recombinetics’ Board. [...]